Literature DB >> 27070120

Improving the reproducibility of voluntary deep inspiration breath hold technique during adjuvant left-sided breast cancer radiotherapy.

Tanja Skyttä1,2, Mika Kapanen1,3, Marko Laaksomaa1, Seppo Peltola1,3, Mikko Haltamo1, Eeva Boman1,3, Simo Hyödynmaa3, Pirkko-Liisa Kellokumpu-Lehtinen1,2.   

Abstract

BACKGROUND: Adjuvant radiotherapy (RT) of left-sided breast cancer (LSBC) with voluntary deep inspiration breath hold (vDIBH) technique reduces the cardiac dose. In this study, the effect of marker block position and the efficacy of breath hold level (BHL) correction based on lateral kV setup images are evaluated to improve the daily reproducibility.
MATERIAL AND METHODS: A total of 148 consecutive LSBC patients treated with vDIBH RT were included in this study. The real-time position management (RPM) marker block was placed on the abdominal wall in 63 patients (group A) and on the sternum in 85 patients (group S). Acquired 900 (group A) + 1040 (group S) orthogonal image pairs were retrospectively analyzed. The actual BHL was determined from the lateral kV images. The height of the BHL gating window in RPM was corrected if errors of the actual BHL exceeded 4 mm. Setup margins were calculated for the chest wall and for bony surrogates of the lymph node regions.
RESULTS: The sternal marker block reduced the random residual errors in the actual BHL (p < 0.05). The BHL correction was required for 26/63 patients in group A and for 26/85 patients in group S. Correction of the BHL window significantly reduced both the systematic and the random residual error in both groups. In patients with lymph node irradiation, the effect of both marker placement and BHL window correction was significant in the superior-inferior direction. Correction of the BHL reduced the mean cardiac dose by 0.5 Gy (p < 0.01) in group A and 0.6 Gy (p < 0.05) in group S.
CONCLUSIONS: Reproducibility of the BHL can be improved by placing the marker block on the sternum and correcting the height of the BHL window based on lateral kV setup images. Acquisition of lateral kV images in the first 3 fractions and once a week during RT is recommended.

Entities:  

Mesh:

Year:  2016        PMID: 27070120     DOI: 10.3109/0284186X.2016.1161823

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Comparison of three differently shaped ROIs in free breathing breast radiotherapy setup using surface guidance with AlignRT®.

Authors:  Marko Laaksomaa; Torsten Moser; Julia Kritz; Kiira Pynnönen; Maija Rossi
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

2.  Dosimetric effects of anatomical deformations and positioning errors in VMAT breast radiotherapy.

Authors:  Maija Rossi; Eeva Boman; Tanja Skyttä; Mikko Haltamo; Marko Laaksomaa; Mika Kapanen
Journal:  J Appl Clin Med Phys       Date:  2018-07-05       Impact factor: 2.102

3.  AlignRT® and Catalyst™ in whole-breast radiotherapy with DIBH: Is IGRT still needed?

Authors:  Marko Laaksomaa; Sebastian Sarudis; Maija Rossi; Turkka Lehtonen; Jani Pehkonen; Jenny Remes; Helmi Luukkanen; Tanja Skyttä; Mika Kapanen
Journal:  J Appl Clin Med Phys       Date:  2019-03       Impact factor: 2.102

4.  Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.

Authors:  Edy Ippolito; Michele Fiore; Alessia Di Donato; Sonia Silipigni; Carla Rinaldi; Patrizia Cornacchione; Erminia Infusino; Cristina Di Venanzio; Carlo Greco; Lucio Trodella; Sara Ramella; Rolando Maria D'Angelillo
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

5.  Target position reproducibility in left-breast irradiation with deep inspiration breath-hold using multiple optical surface control points.

Authors:  Aurora Fassi; Giovanni B Ivaldi; Paola Tabarelli de Fatis; Marco Liotta; Ilaria Meaglia; Patrizia Porcu; Lea Regolo; Marco Riboldi; Guido Baroni
Journal:  J Appl Clin Med Phys       Date:  2018-05-08       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.